Premium
Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nursing Perspective
Author(s) -
Calvaresi Anne E.,
Trabulsi Edouard J.,
Sonzogni Maryann,
Gomella Leonard G.,
Lallas Costas D.,
Wachsmuth Kristen S.
Publication year - 2014
Publication title -
aorn journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 43
eISSN - 1878-0369
pISSN - 0001-2092
DOI - 10.1016/j.aorn.2013.12.013
Subject(s) - cystoscopy , medicine , bladder cancer , perioperative nursing , ambulatory , staffing , nursing , perioperative , general surgery , surgery , cancer , urinary system
Hexaminolevulinate HCl is a diagnostic imaging agent used with blue light during cystoscopy to help detect non–muscle‐invasive bladder cancer. Blue light cystoscopy performed using hexaminolevulinate HCl has been found to detect more papillary non–muscle‐invasive bladder tumors than cystoscopy performed using standard white light. Because bladder instillation and retention requirements of hexaminolevulinate during cystoscopy can affect patient flow in the perioperative setting, this technique necessitates changes in nursing practice and care of patients with known or suspected non–muscle‐invasive bladder cancer. Nursing personnel at one facility followed the AORN guidelines for preoperative patient care in the ambulatory setting to address staffing, preoperative nursing assessment, anesthesia evaluation, and preoperative teaching related to implementing blue light cystoscopy.